TD Waterhouse Canada’s Theratechnologies THTX Stock Holding History

TD Waterhouse Canada’s Portfolio THTX Stock Details THTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-250	Closed	-$792	–	2165
2025 Q3	$792	Sell	250 -17,788	-99%	-$56.8K	﹤0.01%	1912
2025 Q2	$41.5K	Buy	18,038 +7,000	+63%	+$17.2K	﹤0.01%	1160
2025 Q1	$16K	Buy	11,038 +7,500	+212%	+$12.5K	﹤0.01%	1310
2024 Q4	$6.39K	Buy	3,538 +3,288	+1,315%	+$4.47K	﹤0.01%	1506
2024 Q3	$299	Sell	250 -250	-50%	-$339	﹤0.01%	1780
2024 Q2	$694	Hold	500	–	–	﹤0.01%	1755
2024 Q1	$1.08K	Hold	500	–	–	﹤0.01%	1727
2023 Q4	$1.22K	Sell	500 -60,484	-99%	-$91.2K	﹤0.01%	1542
2023 Q3	$166K	Buy	+60,984	New	+$131K	﹤0.01%	671

TD Waterhouse Canada's THTX Position: Q4 2025 in Review

TD Waterhouse Canada sold out of Theratechnologies (THTX) in Q4 2025, closing a stake of 250 shares — an estimated $792 sold.

TD Waterhouse Canada first reported a position in THTX in Q3 2023 and held it in 9 quarters. The position peaked at $166K in Q3 2023. 0 funds tracked by Wall St. Rank hold THTX as of Q4 2025.

TD Waterhouse Canada reported no remaining Theratechnologies position as of Q4 2025 after selling out during the quarter.
TD Waterhouse Canada sold 250 Theratechnologies shares in Q4 2025, an estimated $792.
TD Waterhouse Canada first reported a position in Theratechnologies in Q3 2023 and held it in 9 quarters.
TD Waterhouse Canada's Theratechnologies position peaked at $166K in Q3 2023.
0 funds tracked by Wall St. Rank held Theratechnologies as of Q4 2025.

Based on TD Waterhouse Canada's 13F filing for Q4 2025, filed 27 Jan 2026.